Editorial: Incorporating Phase 0 microdosing as a powerful tool into a new vision of drug development

Weiss, H.M.; Sugiyama, Y.; Duijn, E. van

Editorial: Incorporating Phase 0 microdosing as a powerful tool into a new vision of drug development

article

2024

Weiss, H.M.

Sugiyama, Y.

Duijn, E. van

[No abstract available]

Topics

3R’s drug discovery and development exploratory clinical trials intra-target microdosing (ITM)microdosing modeling and simulations Phase 0 vulnarable populations antibody affinity clinical decision making cytotoxicity drug development drug microdose Editorial human positron emission tomography simulation vision

TNO Identifier

998022

Repository link

https://resolver.tno.nl/uuid:f5a887f8-e1d3-4ad6-aba0-303cce61578b

ISSN

16639812

Source

Frontiers in Pharmacology, 15

Article nr.

1455643

Files

Download weiss-2024-editorial.pdf

Editorial: Incorporating Phase 0 microdosing as a powerful tool into a new vision of drug development

Make TNO yours!